Sinopharm Medicine Holding To Set Up Southwest Pharmaceutical Distribution Center
This article was originally published in PharmAsia News
Executive Summary
Sinopharm Medicine Holding, a subsidiary of Sinopharm, has signed an investment agreement with the Chengdu government to establish a RMB 100 million Sinopharm southwest pharmaceutical distribution center in Chengdu. Aiming to be the top distribution brand in the region, Sinopharm Medicine will first build a modernized pharmaceutical logistics center to transform from a traditional pharmaceutical wholesale enterprise to a progressive distributor. The facility will also provide more extended distribution channels for the southwest company's upstream clients as well as stronger logistics support for downstream customers. (Click here for more - Chinese Language)
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.